Reents Scott T.

Insider Reports History

Location
North Chicago, IL
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Scott T. Reents
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reents Scott T.:

Company Role Class Num Shares Value Price $ Report Date Ownership
AbbVie Inc. EVP, CHIEF FINANCIAL OFFICER Common Stock, $0.01 par value 38,777 $8,999,366 $232.08 27 Feb 2026 Direct
AbbVie Inc. EVP, CHIEF FINANCIAL OFFICER Option (Right to buy) 21,937 $2,556,571 $93.50 18 Feb 2026 Direct

Insider Reports Filed by Reents Scott T.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABBV AbbVie Inc. 27 Feb 2026 1 -$5,021,747 4 EVP, CHIEF FINANCIAL OFFICER 03 Mar 2026, 18:10
ABBV AbbVie Inc. 18 Feb 2026 5 $0 4 EVP, CHIEF FINANCIAL OFFICER 20 Feb 2026, 18:35
ABBV AbbVie Inc. 14 Mar 2025 1 -$3,746,527 4 EVP, CHIEF FINANCIAL OFFICER 18 Mar 2025, 17:00
ABBV AbbVie Inc. 28 Feb 2025 1 -$2,249,684 4 EVP, CHIEF FINANCIAL OFFICER 04 Mar 2025, 17:00
ABBV AbbVie Inc. 13 Feb 2025 5 $0 4 EVP, CHIEF FINANCIAL OFFICER 18 Feb 2025, 17:00
ABBV AbbVie Inc. 23 Feb 2024 4 -$4,591,371 4 EVP, CHIEF FINANCIAL OFFICER 01 Mar 2024, 17:50
ABBV AbbVie Inc. 15 Feb 2024 5 $0 4 EVP, CHIEF FINANCIAL OFFICER 20 Feb 2024, 17:15
ABBV AbbVie Inc. 28 Feb 2023 3 -$4,397,088 4 EVP, CHIEF FINANCIAL OFFICER 02 Mar 2023, 16:04
ABBV AbbVie Inc. 16 Feb 2023 5 $0 4 EVP, CHIEF FINANCIAL OFFICER 21 Feb 2023, 17:10
ABBV AbbVie Inc. 28 Jun 2022 0 $0 3 SVP, Chief Financial Officer 08 Jul 2022, 13:11